Aim Peripheral arterial disease (PAD) and coronary artery disease (CAD) are both caused
by atherosclerosis. Serum lipids and lipoproteins are predictive of the development of …

Background: Little is known about patterns of medication use and lifestyle counseling in
patients with peripheral artery disease (PAD) in the United States. Objectives: The authors …

Background Awareness of the significance of peripheral arterial disease is increasing, but
quantitative estimates of the ensuing burden and the impact of other risk factors remains …

Peripheral arterial occlusive disease (PAD) is a highly prevalent atherosclerotic syndrome
associated with significant morbidity and mortality. It is defined by atherosclerotic obstruction …

Peripheral artery disease (PAD) is a common condition with increasing prevalence in the
United States and worldwide (1, 2). Lower extremity involvement can be devastating for …

Peripheral arterial disease (PAD) is a hallmark of generalized atherosclerosis. Depending
on the specific diagnostic criteria that are being used, the prevalence of PAD may be as high …

Background Although it has been already reported that patients with peripheral artery
disease (PAD) have increased risk of cardiovascular events, not all of the PAD patients have …

BACKGROUND AND OBJECTIVES: Current evidence suggests that modification of
atherosclerosis risk factors plays an important role in reducing adverse cardiovascular …

The pharmacologic treatment of the cardiovascular comorbidities in patients with peripheral
arterial disease (PAD) can have a profound effect on the outcomes of these patients …

Background: Symptoms, severity, and acuteness of peripheral artery disease (PAD) are
major determinants of severe limb symptoms, subsequent risk of cardiovascular events, and …